Physician profile
Leif Rogers
NPI 1649276700
$34,760.63
in general payments reported to CMS, 2019-2025
19 companies · $338 in 2025
The $338 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,126 · 2020: $24K · 2021: $511 · 2022: $2,143 · 2023: $431 · 2024: $976 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,744.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apyx Medical Corporation | $28,998.39 | 2019-2020 | |
| Tela Bio, INC. | $1,433.89 | 2022-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Sientra, INC. | $931.10 | 2020-2022 | |
| Allergan, INC. | $850.45 | 2019-2022 | |
| Tepha INC | $422.55 | 2019-2020 | |
| Revance Therapeutics, INC. | $408.99 | 2024-2025 | Daxxify |
| Galderma Laboratories, L.P. | $405.99 | 2019-2024 | |
| Musculoskeletal Transplant Foundation INC. | $241.45 | 2024-2025 | |
| Abbvie INC. | $220.30 | 2023-2024 | Botox |
| Merz North America, INC. | $210.04 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $200.10 | 2021 | |
| Stryker Corporation | $124.47 | 2023-2025 | Variax, Scopis Ent, Xpress Ent Dilation System |
| Davol INC. | $105.97 | 2022 | |
| Mentor Worldwide LLC | $71.91 | 2019-2022 | |
| Alkermes, INC. | $34.42 | 2024 | Vivitrol |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tei Biosciences INC | $33.45 | 2019 | |
| Integra Lifesciences Corporation | $27.73 | 2022 | |
| Bioventus LLC | $20.57 | 2025 | Exogen Ultrasound Bone Healing System |
| Polynovo North America LLC | $18.86 | 2025 | Novosorb Btm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leif Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.